loader
Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for r1_cep_2002_050___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    GSK

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1GlaxoSmithKline Research & Development Limited Brentford GB

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    GlaxoSmithKline Research & Developm...

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Cefuroxime axetil

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    R1-CEP 2002-050 - Rev 02
    Withdrawn by Holder
    Chemical
    2013-07-02
    2019-10-24
    1300
    blank

    01

    GlaxoSmithKline Research & Developm...

    United Kingdom
    FNCE 2024
    Not Confirmed
    arrow

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2002-050 - Rev 02 of Glaxosmithkline Research & Development Limited Brentford Gb

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2002-050 - Rev 02 of Glaxosmithkline Research & Development Limited Brentford Gb 1

    20

    Glaxosmithkline Research & Development Limited Brentford Gb, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their significant offerings is Cefuroxime axetil, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2002-050 - Rev 02

    This Chemical Type CEP, issued on July 02, 2013, remains in force until October 24, 2019, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1300 associated with this CEP further emphasizes